The National Research Council of Canada Evaluates VoxCell’s Universal Bioink™ to Advance 3D Disease Model Development

Victoria, March 2025—VoxCell BioInnovation is proud to be working with the National Research Council of Canada's (NRC) Human Health Therapeutics (HHT) Research Centre to expand the number of disease models supported by VoxCell’s Universal Bioink™. This initiative aims to reinforce the bioink’s position as a next-generation extracellular matrix (ECM) for use in advanced 3D cell culture and bioprinting workflows.

VoxCell’s proprietary Universal Bioink is being evaluated by biomedical research experts at HHT, led by Dr. Betty Li, to assess printability and biocompatibility across a panel of human cancer cell lines, including those derived from vascular, ovarian, pancreatic, lung, breast, and prostate tissues.

These evaluations are central to confirming the Universal Bioink's versatility and functional performance across different tissue types, laying the groundwork for researchers to develop more reliable and reproducible 3D in vitro models that reflect the complexity of human disease.

Through this project with HHT, VoxCell is accelerating the development of standardized and human-relevant in vitro platforms that can advance both predictive drug testing and disease modelling.

About VoxCell BioInnovation

VoxCell BioInnovation is a leading provider of next-generation in vitro models, powered by our 3D bioprinted, vascularized tissue technology. Our ready-to-perfuse models closely replicate human biology with in vivo–like microvascular networks, enabling nutrient and oxygen delivery, systemic drug distribution, and more predictive therapeutic responses. VoxCell’s end-to-end solution offers researchers and pharmaceutical companies a scalable, ethical alternative to animal testing. Our mission is to reduce reliance on animal models, accelerate preclinical development, and advance more effective therapies for patients.

Want to learn more or collaborate?

Visit our website, connect with us on LinkedIn, or email us at hello@voxcellbio.com.